- Presentations
- 2
- Markets
- 1
Tecartus is a brand of Brexucabtagene autoleucel marketed by Kite Pharma, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Brexucabtagene autoleucel
- Brand owner
- Kite Pharma
- Registered in
- United States
- Strengths and forms
- 1000000/68 mL injectable suspension, 2000000/68 mL injectable suspension
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Tecartus 1000000/68 mL injectable suspensionIntravenous Cold chain | Kite Pharma | US FDA | Available on request |
| Tecartus 2000000/68 mL injectable suspensionIntravenous Cold chain | Kite Pharma | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Tecartus
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.